1.Paris saponin I induces G(2)/M cell cycle arrest and apoptosis in human gastric carcinoma SGC7901 cells.
Meifang, XIAO ; Xiahong, DAI ; Xinchun, HE ; Rongrong, ZHOU ; Baoxin, ZHANG ; Guansheng, HU ; Zebing, HUANG ; Xuegong, FAN
Journal of Huazhong University of Science and Technology (Medical Sciences) 2011;31(6):768-72
The aim of this study was to investigate the effect of Paris saponin I (PS I) on human gastric carcinoma cell growth and apoptosis and to explore the potential mechanisms. The proliferation of SGC7901 cells was monitored by the MTT cell viability assay, while the nuclear morphology of apoptotic cells was assessed by Hoechst 33258 staining. Flow cytometry was performed to analyze the cell cycle progression of propidium iodide (PI)-stained SGC7901 cells and the apoptotic rate of annexin V/PI-stained cells. Western blotting was used to examine the expression of several cell cycle proteins, including cyclin B1 and Cdk1, and the apoptosis-regulated proteins Bcl-2, Bax, cytochrome c, procaspase-9, and procaspase-3. The MTT assay demonstrated that PS I could induce significant dose- and time-dependent inhibition of SGC7901 cell proliferation. Marked morphological changes, including condensation of chromatin, nuclear fragmentation and apoptotic bodies were clearly shown on Hoechst 33258 staining. PSI treatment also resulted in the disruption of the cell cycle at G(2)/M and the induction of apoptosis. Following PSI treatment, the cell cycle-related proteins cyclin B1 and Cdk1 were down-regulated. Expression of the pro-apoptotic protein Bax was increased, while anti-apoptotic protein Bcl-2 decreased. PSI treatment resulted in elevated cytoplasmic cytochrome c and activation of the apoptotic proteases caspase-9 and caspase-3. These data indicate that PS acts as an inhibitor of proli I feration in SGC7901 cells by inducing cell cycle arrest and mitochondria-dependent apoptosis. PSI is a potential therapeutic agent against human gastric carcinoma.
2.Purification and identification of HMGB1 secreted by liver cells and immune cells.
Meifang XIAO ; Xiahong DAI ; Rongrong ZHOU ; Jianping LIU ; Baoxin ZHANG ; Shushan ZHAO ; Xuegong FAN
Journal of Central South University(Medical Sciences) 2011;36(11):1065-1070
OBJECTIVE:
To purify and identify HMGB1 secreted by liver cells HepG2 and immune cells U937.
METHODS:
We cultured the liver cell lines HepG2 and immune cell lines U937, and stimulated them with HMGB1 (400 ng/mL) for 20 h. Then the supernatant was collected. Ultrafiltration centrifugation, CM-Sepharose cation, DEAE-Sepharose anion exchange chromatography, Sephadex G75-gel filtration chromatography, and immunoprecipitation were used for purification. The molecular weight and identity of HMGB1 was confirmed by SDS-PAGE and Western blot.
RESULTS:
A sharp stained protein band with a molecular weight of about 26 kD was obtained by SDS-PAGE analysis and shown to be HMGB1 confirmed by Western blot.
CONCLUSION
High purified HMGB1 can be separated from these two cell lines.
Cell Culture Techniques
;
Electrophoresis, Polyacrylamide Gel
;
methods
;
HMGB1 Protein
;
isolation & purification
;
metabolism
;
Hep G2 Cells
;
Hepatocytes
;
metabolism
;
Humans
;
Monocytes
;
metabolism
;
U937 Cells
3.Paris Saponin Ⅰ Induces G2/M Cell Cycle Arrest and Apoptosis in Human Gastric Carcinoma SGC7901 Cells
XIAO MEIFANG ; DAI XIAHONG ; HE XINCHUN ; ZHOU RONGRONG ; ZHANG BAOXIN ; HU GUANSHENG ; HUANG ZEBING ; FAN XUEGONG
Journal of Huazhong University of Science and Technology (Medical Sciences) 2011;31(6):768-772
The aim of this study was to investigate the effect of Paris saponin Ⅰ (PS Ⅰ ) on human gastric carcinoma cell growth and apoptosis and to explore the potential mechanisms.The proliferation of SGC7901 cells was monitored by the MTT cell viability assay,while the nuclear morphology of apoptotic cells was assessed by Hoechst 33258 staining.Flow cytometry was performed to analyze the cell cycle progression of propidium iodide (PI)-stained SGC7901 cells and the apoptotic rate of annexin V/PI-stained cells.Western blotting was used to examine the expression of several cell cycle proteins,including cyclin B1 and Cdkl,and the apoptosis-regulated proteins Bcl-2,Bax,cytochrome c,procaspase-9,and procaspase-3.The MTT assay demonstrated that PSⅠ could induce significant doseand time-dependent inhibition of SGC7901 cell proliferation.Marked morphological changes,including condensation of chromatin,nuclear fragmentation and apoptotic bodies were clearly shown on Hoechst 33258 staining.PSⅠ treatment also resulted in the disruption of the cell cycle at G2/M and the induction of apoptosis.Following PSⅠ treatment,the cell cycle-related proteins cyclin B 1 and Cdk1 were downregulated.Expression of the pro-apoptotic protein Bax was increased,while anti-apoptotic protein Bcl-2decreased.PSⅠ treatment resulted in elevated cytoplasmic cytochrome c and activation of the apoptotic proteases caspase-9 and caspase-3.These data indicate that PSⅠ acts as an inhibitor of proliferation in SGC7901 cells by inducing cell cycle arrest and mitochondria-dependent apoptosis.PSⅠ is a potential therapeutic agent against human gastric carcinoma.
4.Experiences in construction of infection disease outpatient service
Xiahong DAI ; Bin DENG ; Wei XU ; Qi JIANG ; Jianjian WEI ; Guoping SHENG ; Yongguo LI ; Jianqi LIAN ; Yinghua LAN ; Junxiao LI ; Chunmei HUANG ; Lingling TANG ; Lanjuan LI
Chinese Journal of Clinical Infectious Diseases 2020;13(3):210-217
The infectious disease outpatient service as a frontier is an important fulcrum of public health service. Its standardized construction is an important support for ensuring medical safety, reducing nosocomial infections, and controlling the epidemic of infectious diseases. The sub-specialty outpatient service of infection diseases includes fever outpatient service, intestinal outpatient service, tuberculosis outpatient service, AIDS outpatient service, liver disease outpatient service, etc. According to the characteristics of each subspecialty outpatient service and combining with clinical practice, we elaborated the setting norms of subspecialty outpatient service for common infectious diseases from the perspective of planning and design, building layout, equipment and facilities configuration, staffing, daily management and demonstration.